TRACT Therapeutics

TRACT Therapeutics is a company that focuses on restoring immune balance in patients facing organ transplantation or autoimmune diseases. It provides product candidates that contain T regulatory cells (Tregs) generated ex-vivo from patient’s blood. The company develops a cell-based biologic technology that helps to suppress the patient’s immune response to the transplanted organ, preventing its rejection.